Support activities for animal production
GENE-USE.CO AS
Revenue 2024
NOK 12,000
Operating profit
NOK −230,000
Equity
NOK −35,000
Incorporated
2020
Share capital
NOK 38,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 12k | |
| Total operating costs | 243k | |
| Operating profit (EBIT) | −230k | |
| Net financial items | 2k | |
| Profit for the year | −229k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 40k | |
| of which current assets | 40k | |
| Equity | −35k | |
| Total liabilities | 75k |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.